sophie LIABEUF

Publications

Article dans une revue (220)

Drug‐associated hypopigmentation: Disproportionality signals from the French National Database Mohamad Houssam Al Balkhi,Julien Moragny,Solène Laville,Sophie Liabeuf,Guillaume Chabyet al. Journal of the European Academy of Dermatology and Venereology, 2026, ⟨10.1111/jdv.70473⟩ Article dans une revue hal-05603884v1
Cognitive impairment predicts adverse outcomes in chronic kidney disease Hélène Levassort,Yousra Hassan,Julie Boucquemont,Sophie Liabeuf,Solène Lavilleet al. Kidney International Reports, 2026, 11 (5), pp.106469. ⟨10.1016/j.ekir.2026.106469⟩ Article dans une revue hal-05549977v1
Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance Database Pauline-Eva Pecquet,Julien Moragny,Valérie Gras,Pauline Schiro,Sylvine Pinelet al. Drug Safety, 2026, ⟨10.1007/s40264-025-01643-5⟩ Article dans une revue hal-05461488v1
Optimal patient care in advanced chronic kidney disease progressing to kidney failure Christian Combe,Natalia Alencar de Pinho,Murilo Guedes,Luc Frimat,Denis Fouqueet al. Nature Reviews Nephrology, 2026, ⟨10.1038/s41581-026-01056-2⟩ Article dans une revue hal-05508927v1
Effects of Microplastics and Nanoplastics on the Kidneys Lucie Augey,Jessica Berdougo-Tritz,Aicha Mbarek,Michel Jadoul,Ziad Massyet al. Nephrology Dialysis Transplantation, 2026, ⟨10.1093/ndt/gfag034⟩ Article dans une revue hal-05528288v1
Rôle clé du pharmacien en lien avec le médecin généraliste et le néphrologue dans la prise en charge de la MRC Sophie Liabeuf,Margot Pauwels,Solène Laville,Ziad Massy Annales Pharmaceutiques Françaises, 2026, ⟨10.1016/j.pharma.2026.03.004⟩ Article dans une revue hal-05579629v1
WCN26-8163 Impact of renin-angiotensin system inhibitors discontinuation in advanced chronic kidney disease: a target trial emulation Bénédicte Sautenet,Valentin Maisons,Margaux Costes-Albrespic,Sophie Liabeuf,Solène Lavilleet al. Kidney International Reports, 2026, 11 (4), pp.104274. ⟨10.1016/j.ekir.2026.104274⟩ Article dans une revue hal-05568907v1
Anticholinergic Burden and Progression to Kidney Replacement Therapy Agathe Mouheb,Ziad Massy,Marie Metzger,Hélène Levassort,Marion Pépinet al. Kidney International Reports, 2026, pp.106552. ⟨10.1016/j.ekir.2026.106552⟩ Article dans une revue hal-05604059v1
Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes Agathe Mouheb,Marie Metzger,Natalia Alencar de Pinho,Christian Jacquelinet,Maurice Lavilleet al. Scientific Reports, 2026, 16 (1), pp.2653. ⟨10.1038/s41598-025-25632-x⟩ Article dans une revue hal-05472245v1
Cholinergic system in patients with chronic kidney disease: cognitive and renal implications. Hong Xu,Maria Eriksdotter,Gaye Hafez,Sumonto Mitra,Annette Bruchfeldet al. Nephrology Dialysis Transplantation, 2025, 40 (11), pp.2026-2037. ⟨10.1093/ndt/gfaf029⟩ Article dans une revue hal-04946396v1
Association between urate-lowering therapy and kidney failure in patients with chronic kidney disease Agathe Mouheb,Oriane Lambert,Natalia Alencar de Pinho,Christian Jacquelinet,Maurice Lavilleet al. Journal of Nephrology, 2025, 38 (2), pp.597-607. ⟨10.1007/s40620-024-02179-0⟩ Article dans une revue hal-04877389v1
International Variations in Chronic Kidney Disease Patients’ Pain Experience and its Management Rupesh Raina,Nikhil Nair,Rohan Kumar,Kush Doshi,Natalia Alencar-de Pinhoet al. Clinical Kidney Journal, 2025, 19 (1), pp.sfaf346. ⟨10.1093/ckj/sfaf346⟩ Article dans une revue hal-05416239v1
A longitudinal analysis of haemoglobin levels and major cardiovascular events Lisa Le Gall,Natalia Alencar de Pinho,Jérôme Harambat,Christian Combe,Tilman Drüekeet al. Nephrology Dialysis Transplantation, 2025, ⟨10.1093/ndt/gfaf221⟩ Article dans une revue hal-05368588v1
Homocitrulline is Associated with Cardiovascular Outcomes in Non-Dialysis Patients with CKD Solène Laville,Stéphane Jaisson,Philippe Gillery,Anaïs Okwieka,Natalia Alencar de Pinhoet al. Kidney360, 2025, ⟨10.34067/KID.0000000797⟩ Article dans une revue hal-05019389v1
Translational research on cognitive impairment in chronic kidney disease Carsten Wagner,Ziad Massy,Giovambattista Capasso,Francesco Mattace-Raso,Marion Pepinet al. Nephrology Dialysis Transplantation, 2025, 40 (4), pp.621-631. ⟨10.1093/ndt/gfae229⟩ Article dans une revue hal-05590395v1
Furosemide and the Symptom Burden: The Potential Mediating Role of Uremic Toxins in Patients with CKD Margaux Costes-Albrespic,Sophie Liabeuf,Islam-Amine Larabi,Solène Laville,Bénédicte Stengelet al. Toxins, 2025, 17 (11), pp.541. ⟨10.3390/toxins17110541⟩ Article dans une revue hal-05391301v1
Association between serum interleukin 8 levels and cardiovascular events in patients with chronic kidney disease Maxime Pluquet,Ziad Massy,Youssef Bennis,Said Kamel,Nicolas Mansencalet al. Clinical Kidney Journal, 2025, 18 (12), pp.sfaf336. ⟨10.1093/ckj/sfaf336⟩ Article dans une revue hal-05411849v1
[Poster]#1588 Homocitrulline is associated with cardiovascular outcomes in non-dialysis patients with chronic kidney disease Solene Laville,Stéphane Jaisson,Philippe Gillery,Anais Okwieka,Natalia Alencar de Pinhoet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_3), ⟨10.1093/ndt/gfaf116.0542⟩ Article dans une revue hal-05349388v1
Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD Carmine Zoccali,Francesca Mallamaci,Carsten a Wagner,Robert Unwin,Maiken Nedergaardet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_2), pp.ii64-ii75. ⟨10.1093/ndt/gfae259⟩ Article dans une revue hal-05237159v1
Care pathways for patients with cognitive impairment and chronic kidney disease Marion Pépin,Konstantinos Giannakou,Hélène Levassort,Ana Farinha,Mickaël Bobotet al. Nephrology Dialysis Transplantation, 2025, 40, pp.ii28 - ii36. ⟨10.1093/ndt/gfae264⟩ Article dans une revue hal-05375779v1
[Poster]#132 Exploring the Interactions between drugs and metabolic disturbances in CKD: an example with oral anticoagulants Touria Mernissi,Stéphane Jaisson,Pierre Spicher,Said Kamel,Anais Okwiekaet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_3), ⟨10.1093/ndt/gfaf116.1537⟩ Article dans une revue hal-05349362v1
Anticholinergic burden and incident dementia: a Swedish nationwide case-control study Nanbo Zhu,Maria Eriksdotter,Sophie Liabeuf,Edwin Tan,Kristina Johnellet al. Alzheimer's Research and Therapy, 2025, 17 (1), pp.227. ⟨10.1186/s13195-025-01883-8⟩ Article dans une revue hal-05328510v1
Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate Sophie Liabeuf,Jessica Berdougo-Tritz,Lucie Augey,Aïcha Mbarek,Michel Jadoulet al. Fundamental & Clinical Pharmacology, 2025, 39 (4), ⟨10.1111/fcp.70037⟩ Article dans une revue hal-05178823v1
Association of phenylacetylglutamine and cognitive impairment in chronic kidney disease Hélène Levassort,Julie Boucquemont,Sophie Liabeuf,Solène Laville,Céline Langeet al. Kidney International Reports, 2025, 10 (8), pp.2720-2731. ⟨10.1016/j.ekir.2025.05.037⟩ Article dans une revue hal-05093949v1
Transporter-Mediated Interactions Between Uremic Toxins and Drugs: A Hidden Driver of Toxicity in Chronic Kidney Disease Pierre Spicher,François Brazier,Solène Laville,Sophie Liabeuf,Saïd Kamelet al. International Journal of Molecular Sciences, 2025, 26 (13), pp.6328. ⟨10.3390/ijms26136328⟩ Article dans une revue hal-05145108v1
Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD Margaux Costes-Albrespic,Natalia Alencar de Pinho,Islam Amine Larabi,Carolla El Chamieh,Solène Lavilleet al. Kidney International Reports, 2025, 10 (7), pp.2165-2177. ⟨10.1016/j.ekir.2025.04.040⟩ Article dans une revue hal-05185285v1
Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors Alexandre Andrade,Maie Bachmann,Mickaël Bobot,Annette Bruchfeld,Ivo Fridolinet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_2), pp.ii18-ii27. ⟨10.1093/ndt/gfae256⟩ Article dans une revue hal-05590446v1
[Poster]#1856 Exploring sex-based variations in prescription patterns and adverse drug reactions in chronic kidney disease Solene Laville,Agathe Mouheb,Natalia Alencar de Pinho,Maurice Laville,Christian Combeet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_3), ⟨10.1093/ndt/gfaf116.0543⟩ Article dans une revue hal-05349381v1
Untangling causality in nephrology: the example of CKD-MBD and disease progression Solène Laville,Sophie Liabeuf Kidney International, 2025, 108 (6), pp.993-995. ⟨10.1016/j.kint.2025.08.017⟩ Article dans une revue hal-05375308v1
Response to the Letter to the Editor Entitled &quot;Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits M. Costes-Albrespic,N. Alencar de Pinho,Z.A. Massy,S. Liabeuf Kidney International Reports, 2025, 10 (8), pp.2877-2878. ⟨10.1016/j.ekir.2025.05.048⟩ Article dans une revue hal-05101760v1
The role of the intestinal microbiome in cognitive decline in patients with kidney disease Carsten Wagner,Isabelle Frey-Wagner,Alberto Ortiz,Robert Unwin,Robert Unwinet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_2), pp.ii4-ii17. ⟨10.1093/ndt/gfae253⟩ Article dans une revue hal-04993584v1
Causes of Mortality in Intensive Care Units for Patients with Chronic Inflammatory Diseases from the French National Health Data System Yannis Hamidou,Jean Marc Sobhy Danial,Thibault Balcaen,Sophie Liabeuf,Solène Lavilleet al. Journal of Clinical Medicine, 2025, 14 (6), pp.2000. ⟨10.3390/jcm14062000⟩ Article dans une revue hal-05019503v1
Exploring the Interactions between Drugs and Metabolic Disturbances in CKD Touria Mernissi,Stéphane Jaisson,Pierre Spicher,Said Kamel,Anaïs Okwiekaet al. Kidney360, 2025, ⟨10.34067/KID.0000000862⟩ Article dans une revue hal-05129261v1
Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease. Solène Laville,Agathe Mouheb,Ziad Massy,Christian Jacquelinet,Maurice Lavilleet al. Nephrology Dialysis Transplantation, 2025, 40 (12), pp.2379-2389. ⟨10.1093/ndt/gfaf125⟩ Article dans une revue hal-05157774v1
QT-Prolonging Medications: Prevalence of Use and Associated Risks in CKD Sophie Liabeuf,Jessica Berdougo-Tritz,Lucie Augey,Solène Laville,Aïcha Mbareket al. Nephrology Dialysis Transplantation, 2025, Online ahead of prin. ⟨10.1093/ndt/gfaf196⟩ Article dans une revue hal-05294607v1
[Poster]#794 Phenylacetylglutamine's role in the link between uremic toxins and cognition in chronic kidney disease: a CKD-REIN cohort study Helene Levassort,Julie Boucquemont,Sophie Liabeuf,Solene Laville,Luc Frimatet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_3), pp.i961-i962. ⟨10.1093/ndt/gfaf116.0495⟩ Article dans une revue hal-05349394v1
[Poster]#2259 Serum interleukin-8 concentrations, associated factors, and associated cardiovascular risk in patients with moderate-to-advanced chronic kidney disease Maxime Pluquet,Said Kamel,Natalia Alencar de Pinho,Luc Frimat,Christian Combeet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_3), pp.i945. ⟨10.1093/ndt/gfaf116.0485⟩ Article dans une revue hal-05349400v1
Évaluation du risque hémorragique lors de la co-prescription des anticoagulants oraux et des inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) : méthodologie d’une étude émulant un essai contrôlé randomisé à partir du SNDS en France Solène Laville,Olivier Varennes,Simon Soudet,Marie-Antoinette Sevestre,Sophie Liabeuf Vascular Diseases, 2025, 50 (1), pp.49. ⟨10.1016/j.vasdi.2025.01.037⟩ Article dans une revue hal-05038599v1
Uncovering the link between kynurenic acid pathway and kidney failure Carolla El Chamieh,Sophie Liabeuf,Islam Amine Larabi,Natalia Alencar de Pinho,Margaux Costes-Albrespicet al. Kidney International Reports, 2025, 10 (5), pp.1404-1414. ⟨10.1016/j.ekir.2025.02.024⟩ Article dans une revue hal-04982161v1
Chemotherapy-related cognitive impairment and kidney dysfunction Mariadelina Simeoni,Michele Mulholland,Biruh Workeneh,Anna Capasso,Gaye Hafezet al. Nephrology Dialysis Transplantation, 2025, 40 (Supplement_2), pp.ii54-ii63. ⟨10.1093/ndt/gfae249⟩ Article dans une revue hal-04993600v1
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease Solène Laville,Janice Vendar,Ziad Massy,Valérie Gras-Champel,Julien Moragnyet al. Clinical Kidney Journal, 2024, ⟨10.1093/ckj/sfae357⟩ Article dans une revue hal-04794868v1
The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD‐REIN cohort study Fabrice Bonnet,Beverley Balkau,Oriane Lambert,Yakhara Diawara,Christian Combeet al. Diabetes, Obesity and Metabolism, 2024, ⟨10.1111/dom.15507⟩ Article dans une revue hal-04484106v1
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations Sophie Liabeuf,Roberto Minutolo,Jürgen Floege,Carmine Zoccali Clinical Kidney Journal, 2024, 18 (2), pp.sfae380. ⟨10.1093/ckj/sfae380⟩ Article dans une revue hal-04835354v1
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial Maxime Pluquet,Solène Laville,François Brazier,Pablo Ureña-Torres,Najeh El Esperet al. Clinical Kidney Journal, 2024, ⟨10.1093/ckj/sfae343⟩ Article dans une revue hal-04784563v1
De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease Maxime Pluquet,Marie Metzger,Christian Jacquelinet,Christian Combe,Denis Fouqueet al. Frontiers in Pharmacology, 2024, 15, ⟨10.3389/fphar.2024.1375838⟩ Article dans une revue hal-04639466v1
#1135 Evaluation of the adequacy of urate lowering therapy prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort Agathe Mouheb,Oriane Lambert,Natalia Alencar de Pinho,Christian Jacquelinet,Maurice Lavilleet al. Nephrology Dialysis Transplantation, 2024, 39 (Supplement_1), pp.gfae069.689. ⟨10.1093/ndt/gfae069.689⟩ Article dans une revue hal-04588854v1
#2856 Sleep disturbances in non-dialysis dependent chronic kidney disease—The CKD-REIN cohort study Benedicte Stengel,Emilie Moutard,Marie Metzger,Isabelle Jaussent,Solene Lavilleet al. Nephrology Dialysis Transplantation, 2024, 39 (Supplement_1), pp.89-90 Meeting Abstract 2856. ⟨10.1093/ndt/gfae069.047⟩ Article dans une revue hal-04684809v1
#1091 Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease Sophie Liabeuf,Ziad Massy,Valérie Gras-Champel,Luc Frimat,Maurice Lavilleet al. Nephrology Dialysis Transplantation, 2024, 39 (Supplement_1), pp.1902-1903 Meeting abstract 1091. ⟨10.1093/ndt/gfae069.1165⟩ Article dans une revue hal-04684240v1
The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment Agathe Mouheb,Hélène Levassort,Ziad Massy,Christian Jacquelinet,Maurice Lavilleet al. Journal of the American Geriatrics Society, 2024, Online ahead of print. ⟨10.1111/jgs.19283⟩ Article dans une revue hal-04813727v1
Antihypertensive Treatment Patterns in CKD Stage 3 and 4: The CKD-REIN Cohort Study Margaux Costes-Albrespic,Sophie Liabeuf,Solène Laville,Christian Jacquelinet,Christian Combeet al. Kidney medicine, 2024, pp.100912. ⟨10.1016/j.xkme.2024.100912⟩ Article dans une revue hal-04731989v1
Sex and the Risk of Atheromatous and Non-Atheromatous Cardiovascular Disease in CKD: Findings From the CKD-REIN Cohort Study Anne-Laure Faucon,Oriane Lambert,Ziad Massy,Tilman Drüeke,Christian Combeet al. American Journal of Kidney Diseases, 2024, 84 (5), pp.546-556. ⟨10.1053/j.ajkd.2024.04.013⟩ Article dans une revue hal-04627418v1
Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysis: a nationwide registry study Solène Laville,Cécile Couchoud,Marc Bauwens,Henri Vacher Coponat,Gabriel Choukrounet al. Nephrology Dialysis Transplantation, 2024, ⟨10.1093/ndt/gfae042⟩ Article dans une revue hal-04473005v1
Drugs with a negative impact on cognitive functions (Part 3): Antibacterial agents in patients with chronic kidney disease Sophie Liabeuf,Gaye Hafez,Vesna Pešić,Goce Spasovski,Mickael Bobotet al. Clinical Kidney Journal, 2024, 17 (8), pp.sfae174. ⟨10.1093/ckj/sfae174⟩ Article dans une revue hal-04616822v1
#280 Effectiveness and safety of direct oral anticoagulants vs VKA in patients on chronic dialysis: a target trial emulation using nationwide registry data Solene Laville,Cécile Couchoud,Gabriel Choukroun,Sophie Liabeuf Nephrology Dialysis Transplantation, 2024, 39 (Supplement_1), ⟨10.1093/ndt/gfae069.078⟩ Article dans une revue hal-04588835v1
CARDIOVASCULAR IMPACT OF DISCONTINUATION OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN ADVANCED CHRONIC KIDNEY DISEASE Valentin Maisons,Costes -Albrespi Margaux,Liabeuf Sophie,Laville Solene,Massy Ziadet al. Journal of Hypertension, 2024, 42 (Suppl 1), pp.e157. ⟨10.1097/01.hjh.0001020936.76632.49⟩ Article dans une revue hal-04664995v1
Urea Level and Depression in Patients with Chronic Kidney Disease Hélène Levassort,Julie Boucquemont,Oriane Lambert,Sophie Liabeuf,Solene Lavilleet al. Toxins, 2024, 16 (7), pp.326. ⟨10.3390/toxins16070326⟩ Article dans une revue hal-04661492v1
#431 Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes Maxime Pluquet,Said Kamel,Natalia Alencar de Pinho,Mansencal Nicolas,Christian Combeet al. Nephrology Dialysis Transplantation, 2024, 39 (Supplement_1), ⟨10.1093/ndt/gfae069.051⟩ Article dans une revue hal-04588807v1
Medication-overuse headache: A pharmacovigilance study in France Mohamad Houssam Al Balkhi,Julien Moragny,Solène Laville,Sophie Liabeuf,Pauline-Eva Pecquetet al. Therapies, 2024, 79 (5), pp.565-575. ⟨10.1016/j.therap.2024.02.001⟩ Article dans une revue hal-04483201v1
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review Michelangela Barbieri,Paolo Chiodini,Piergiacomo Di Gennaro,Gaye Hafez,Sophie Liabeufet al. Pharmacological Research, 2024, 203, pp.107146. ⟨10.1016/j.phrs.2024.107146⟩ Article dans une revue hal-04510108v1
Association between Urate-Lowering Therapy and Kidney Failure in Patients with CKD Agathe Mouheb,Oriane Lambert,Natalia Alencar de Pinho,Christian Jacquelinet,Maurice Lavilleet al. Journal of the American Society of Nephrology, 2024, 35 (10S), pp.Poster TH-PO1074. ⟨10.1681/ASN.20242w670vb7⟩ Article dans une revue hal-04759955v1
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes Maxime Pluquet,Said Kamel,Natalia Alencar de Pinho,Nicolas Mansencal,Christian Combeet al. Clinical Kidney Journal, 2024, 17 (4), pp.sfae046. ⟨10.1093/ckj/sfae046⟩ Article dans une revue hal-04626802v2
Cognitive impairment in CKD patients: a guidance document by the CONNECT network Davide Bolignano,Mariadelina Simeoni,Gaye Hafez,Marion Pepin,Antonio Galloet al. Clinical Kidney Journal, 2024, 18 (2), pp.sfae294. ⟨10.1093/ckj/sfae294⟩ Article dans une revue hal-04720847v1
#2379 Acute kidney injury as a key predictor of major adverse cardiovascular events in chronic kidney disease patients Nans Florens,Estelle Aymes,Victoria Gauthier,Luc Frimat,Maurice Lavilleet al. Nephrology Dialysis Transplantation, 2024, 39 (Supplement_1), pp.Meeting Abstract 2379. ⟨10.1093/ndt/gfae069.113⟩ Article dans une revue hal-04684064v1
Polypharmacy in Patients with Chronic Kidney Disease Ilse Oosting,Julia M.T. Colombijn,Lotte Kaasenbrood,Sophie Liabeuf,Solène Lavilleet al. Kidney360, 2024, 5 (6), pp.841-850. ⟨10.34067/KID.0000000000000447⟩ Article dans une revue hal-04561915v1
Acute kidney injury as a key predictor of cardiovascular events in chronic kidney disease patients: the CKD-REIN study Nans Florens,Estelle Aymes,Victoria Gauthier,Luc Frimat,Maurice Lavilleet al. Clinical Kidney Journal, 2024, ⟨10.1093/ckj/sfae337⟩ Article dans une revue hal-04837069v1
Rôle des toxines urémiques dans la genèse des complications de la maladie rénale chronique S. Liabeuf,T.B. Drueke,Z.A. Massy Bulletin de l'Académie Nationale de Médecine, 2023, 207 (3), pp.238-246. ⟨10.1016/j.banm.2022.10.018⟩ Article dans une revue hal-04125000v1
Statin therapy and the incidence of atherosclerotic cardiovascular events after kidney transplantation Charifa Nazoiri,Sophie Liabeuf,François Brazier,Alban Nowak,Youssef Benniset al. Nephrology Dialysis Transplantation, 2023, ⟨10.1093/ndt/gfad217⟩ Article dans une revue hal-04239445v1
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease Konstantinos Giannakou,Aleksandra Golenia,Sophie Liabeuf,Jolanta Malyszko,Francesco Mattace-Rasoet al. Frontiers in Medicine, 2023, 10, ⟨10.3389/fmed.2023.1215583⟩ Article dans une revue hal-04192948v1
Association Between Serum Kynurenine Levels and Cardiovascular Outcomes and Overall Mortality in CKD Carolla El Chamieh,Natalia Alencar de Pinho,Oriane Lambert,Denis Fouque,Luc Frimatet al. Journal of the American Society of Nephrology, 2023, 34 (11S), pp.664-664. ⟨10.1681/ASN.20233411S1664a⟩ Article dans une revue hal-04580943v1
Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment Marion Pépin,Aleksandra Klimkowicz-Mrowiec,Olivier Godefroy,Pilar Delgado,Sol Carriazoet al. European Journal of Neurology, 2023, ⟨10.1111/ene.15928⟩ Article dans une revue hal-04137872v1
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients Gaye Hafez,Jolanta Malyszko,Aleksandra Golenia,Aleksandra Klimkowicz-Mrowiec,Ana Carina Ferreiraet al. Clinical Kidney Journal, 2023, 16 (12), pp.2378-2392. ⟨10.1093/ckj/sfad239⟩ Article dans une revue hal-04264875v1
Patient- and Provider-Related Factors Associated with Changes in Antihypertensive Treatment in CKD Margaux Costes-Albrespic,Sophie Liabeuf,Solene Laville,Denis Fouque,Maurice Lavilleet al. Journal of the American Society of Nephrology, 2023, 34 (11S), pp.379-379. ⟨10.1681/ASN.20233411S1379a⟩ Article dans une revue hal-04580933v1
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor Sophie Liabeuf,Vesna Pešić,Goce Spasovski,Romaldas Maciulaitis,Mickaël Bobotet al. Clinical Kidney Journal, 2023, 16 (12), pp.2365-2377. ⟨10.1093/ckj/sfad241⟩ Article dans une revue hal-04256633v1
Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular events Lisa Le Gall,Jérôme Harambat,Christian Combe,Viviane Philipps,Cécile Proust-Limaet al. Nephrology Dialysis Transplantation, 2023, ⟨10.1093/ndt/gfad235⟩ Article dans une revue hal-04284734v1
Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients Aurelie Lenglet,Stéphane Jaisson,Philippe Gillery,Souleiman El Balkhi,Sophie Liabeufet al. Amino Acids, 2023, 55 (10), pp.1455-1460. ⟨10.1007/s00726-023-03306-0⟩ Article dans une revue hal-04176949v1
Quantitative determination of plasma free and total concentrations of antivitamin K drugs using a new sensitive and rapid LC-MS/MS method: Application in hemodialysis patients Touria Mernissi,Julien Demagny,Mailys Le Guyader,Marianne Renou,Gabriel Choukrounet al. Clinica Chimica Acta, 2023, 548, pp.117498. ⟨10.1016/j.cca.2023.117498⟩ Article dans une revue hal-04172553v1
Drugs associated with incident fragility fractures in kidney transplant recipients Benjamin Batteux,Alban Nowak,Alice Séjourné,Clémence Penet,Kamel Masmoudiet al. Clinical Kidney Journal, 2023, 16 (3), pp.571-584. ⟨10.1093/ckj/sfac265⟩ Article dans une revue hal-04021946v1
Association Between Longitudinal eGFR and Sudden Cardiac Death Among CKD Patients Jean Delannoy,Anne-Laure Faucon,Marie Metzger,Sophie Liabeuf,Ziad Massyet al. Journal of the American Society of Nephrology, 2023, 34 (11S), pp.1044-1045. ⟨10.1681/ASN.20233411S11044c⟩ Article dans une revue hal-04580927v1
Ionized Magnesium Levels In Patients With Moderate-To-Advanced Chronic Kidney Disease: Relationship With Total Magnesium And Associated Factors Maxime Pluquet,Solene Laville,Céline Lange,Aghiles Hamroun,Maurice Lavilleet al. Nephrology Dialysis Transplantation, 2023, 38 (Supplement_1), pp.#4457. ⟨10.1093/ndt/gfad063c_4457⟩ Article dans une revue hal-04196983v1
Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease Mathilde Prezelin-Reydit,Christian Combe,Denis Fouque,Luc Frimat,Christian Jacquelinetet al. Scientific Reports, 2023, 13 (1), pp.3952. ⟨10.1038/s41598-023-30902-7⟩ Article dans une revue hal-04032437v1
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD Solène Laville,Valérie Gras-Champel,Aghilès Hamroun,Julien Moragny,Oriane Lambertet al. American Journal of Kidney Diseases, 2023, 83 (5), pp.601-614.e1. ⟨10.1053/j.ajkd.2023.09.012⟩ Article dans une revue hal-04288693v1
Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease Carolla El Chamieh,Islam Amine Larabi,Natalia Alencar de Pinho,Oriane Lambert,Christian Combeet al. Clinical Kidney Journal, 2023, 17 (1), pp.sfad248. ⟨10.1093/ckj/sfad248⟩ Article dans une revue hal-04335540v1
A new approach for cognitive impairment pattern in chronic kidney disease Hélène Levassort,Julie Boucquemont,Natalia Alencar de Pinho,Oriane Lambert,Catherine Helmeret al. Nephrology Dialysis Transplantation, 2023, ⟨10.1093/ndt/gfad244⟩ Article dans une revue hal-04321443v1
Maladie rénale chronique et pratiques néphrologiques en France : leçons de la cohorte CKD-REIN, 2013-2023 Natalia Alencar de Pinho,Marie Metzger,Aghilès Hamroun,Solène Laville,Mathilde Prezelin-Reyditet al. Néphrologie & Thérapeutique, 2023, 19 (4), pp.1-18. ⟨10.1684/ndt.2023.35⟩ Article dans une revue hal-04167331v1
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease Carolla El Chamieh,Islam Amine Larabi,Solène Laville,Christian Jacquelinet,Christian Combeet al. Toxins, 2023, 15 (4), pp.276. ⟨10.3390/toxins15040276⟩ Article dans une revue hal-04089104v1
Ionized and Total Magnesium Levels and Cardiovascular Risk in Patients with CKD Solene Laville,Maxime Pluquet,Nicolas Mansencal,Denis Fouque,Maurice Lavilleet al. Journal of the American Society of Nephrology, 2023, 34 (11S), pp.659-659. ⟨10.1681/ASN.20233411S1659b⟩ Article dans une revue hal-04580938v1
Effect of statins on the incidence of cardiovascular evenrs after kidney transplantation Benjamin Batteux,Charifa Nazoiri,François Brazier,Alban Nowak,Youssef Beniset al. Nephrology Dialysis Transplantation, 2023, 38 (Supplement_1), pp.5647. ⟨10.1093/ndt/gfad063d_5647⟩ Article dans une revue hal-04196957v1
Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase (R)) B. Batteux,Youcef Bennis,S. Bodeau,K. Masmoudi,A. S. Hurtel-Lemaireet al. Fundamental & Clinical Pharmacology, 2022, 36 (1, SI), pp.159 Article dans une revue hal-03712136v1
Cognitive Performance in Patients With Chronic Kidney Disease: Results From the CKD-Rein Cohort Study Marion Pepin,Julie Boucquemont,Monica Turinici,Helene Levassort,Lynda Cheddaniet al. Nephrology Dialysis Transplantation, 2022, 37 (3), pp.I363-I364. ⟨10.1093/ndt/gfac071.034⟩ Article dans une revue hal-03732939v1
INCIDENCE OF CAUSE-SPECIFIC CARDIOVASCULAR EVENTS IN MEN AND WOMEN WITH CKD Anne-Laure Faucon,Oriane Lambert,Natalia Alencar De Pinho,Carole Ayav,Christian Combeet al. Nephrology Dialysis Transplantation, 2022, 37 (3), pp.I360-I361 Article dans une revue hal-03732945v1
Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings? Carolla El Chamieh,Sophie Liabeuf,Ziad Massy Toxins, 2022, 14 (4), ⟨10.3390/toxins14040280⟩ Article dans une revue hal-03659986v1
Cognitive performance is associated with glomerular filtration rate in patients with chronic kidney disease: results from the CKD-REIN cohort Marion Pépin,Hélène Levassort,Julie Boucquemont,Oriane Lambert,Natalia Alencar de Pinhoet al. Journal of Neurology, Neurosurgery and Psychiatry, 2022, jnnp-2022-330347. ⟨10.1136/jnnp-2022-330347⟩ Article dans une revue hal-03957951v1
The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients Camille Andre,Touria Mernissi,Gabriel Choukroun,Youssef Bennis,Saïd Kamelet al. Toxins, 2022, 14 (1), ⟨10.3390/toxins14010015⟩ Article dans une revue hal-03595112v1
The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction Regiane Stafim Da Cunha,Carolina Amaral Bueno Azevedo,Carlos Alexandre Falconi,Fernanda Fogaca Ruiz,Sophie Liabeufet al. Toxins, 2022, 14 (3), ⟨10.3390/toxins14030177⟩ Article dans une revue hal-03641408v1
Potential Interactions between Uraemic Toxins and Drugs: An Application in Kidney Transplant Recipients Treated with Calcineurin Inhibitors. Camille André,Gabriel Choukroun,Youssef Bennis,Said Kamel,Anne Sophie Lemaire-Hurtelet al. Nephrology Dialysis Transplantation, 2022, 37 (11), pp.2284--2292. ⟨10.1093/ndt/gfab114⟩ Article dans une revue hal-03832989v1
Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review. Maxime Pluquet,Said Kamel,Gabriel Choukroun,Sophie Liabeuf,Solène M. Laville Toxins, 2022, 14 (9), ⟨10.3390/toxins14090637⟩ Article dans une revue hal-03792025v1
Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R)) A. Dernoncourt,S. Liabeuf,Youcef Bennis,K. Masmoudi,V. Gras-Champelet al. Fundamental & Clinical Pharmacology, 2022, 36 (1, SI), pp.32 Article dans une revue hal-03712137v1
SERUM UREA LEVELS AND CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE Solène M Laville,Aymeric Couturier,Oriane Lambert,Marie Metzger,Mansencal Nicolaset al. Nephrology Dialysis Transplantation, 2022, 37 (3), pp.I358-I359 Article dans une revue hal-03732935v1
Sortilin, carbamylation, and cardiovascular calcification in chronic kidney disease Ziad A. Massy,Sophie Liabeuf Kidney International, 2022, 101 (3), pp.456-459. ⟨10.1016/j.kint.2021.11.027⟩ Article dans une revue hal-03611975v1
Erratum to: Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment Marion Pépin,Ana Carina Ferreira,Mustafa Arici,Maie Bachmann,Michelangela Barbieriet al. Nephrology Dialysis Transplantation, 2022, 37 (6), pp.1199-1199. ⟨10.1093/ndt/gfab339⟩ Article dans une revue hal-04011643v1
New Insights into Acute-on-Chronic Kidney Disease in Nephrology Patients: The CKD-REIN Study. Aghilès Hamroun,Luc Frimat,Maurice Laville,Marie Metzger,Christian Combeet al. Nephrology Dialysis Transplantation, 2022, 37 (9), pp.1700--1709. ⟨10.1093/ndt/gfab249⟩ Article dans une revue hal-03760907v1
Barriers to conservative care from patients' and nephrologists' perspectives: The CKD-REIN Study A. Hamroun,E. Speyer,C. Ayav,C. Combe,D. Fouqueet al. Nephrology Dialysis Transplantation, 2022, 37 (12), pp.2438-2448. ⟨10.1093/ndt/gfac009⟩ Article dans une revue inserm-03752850v1
Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases. Amayelle Rey,Valérie Gras,Julien Moragny,Gabriel Choukroun,Kamel Masmoudiet al. Frontiers in Pharmacology, 2022, 13, pp.899164. ⟨10.3389/fphar.2022.899164⟩ Article dans une revue hal-03740515v1
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment Marion Pepin,Ana Carina Ferreira,Mustafa Arici,Maie Bachman,Michelangela Barbieriet al. Nephrology Dialysis Transplantation, 2022, 37 (2), pp.23-32. ⟨10.1093/ndt/gfab262⟩ Article dans une revue hal-03578427v1
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities Sophie Liabeuf,Jean-Luc Schmit,Jean-Philippe Lanoix,Sandrine Castelain,Frederic Blochet al. Journal of Nutrition, Health & Aging, 2022, 26 (1), pp.57-63. ⟨10.1007/s12603-021-1713-4⟩ Article dans une revue hal-03578461v1
Associations between Th1-mediated diseases and omalizumab: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase (R)) S. Magnifico,A. Dernoncourt,K. Masmoudi,S. Liabeuf,V. Gras-Champelet al. Fundamental & Clinical Pharmacology, 2022, 36 (1, SI), pp.14-15 Article dans une revue hal-03712138v1
Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury Amayelle Rey,Valérie Gras-Champel,Thibaut Balcaen,Gabriel Choukroun,Kamel Masmoudiet al. Journal of Nephrology, 2022, 35 (3), pp.955-968. ⟨10.1007/s40620-021-01174-z⟩ Article dans une revue hal-03819929v1
Risk Factors for and Characteristics of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries. Amayelle Rey,Valérie Gras-Champel,Gabriel Choukroun,Kamel Masmoudi,Sophie Liabeuf Fundamental & Clinical Pharmacology, 2022, 36 (4), pp.750--761. ⟨10.1111/fcp.12758⟩ Article dans une revue hal-03735623v1
Five-Year Symptom Trajectories in Nondialysis-Dependent CKD Patients. Moustapha Faye,Karine Legrand,Lisa Le Gall,Karen Leffondre,Abdou Y. Omorouet al. Clinical Journal of the American Society of Nephrology, 2022, 17 (11), pp.1588-1597. ⟨10.2215/CJN.06140522⟩ Article dans une revue hal-03838383v1
Urea levels and cardiovascular disease in patients with chronic kidney disease Solène M Laville,Aymeric Couturier,Oriane Lambert,Marie Metzger,Nicolas Mansencalet al. Nephrology Dialysis Transplantation, 2022, 38 (1), pp.184-192. ⟨10.1093/ndt/gfac045⟩ Article dans une revue hal-03717300v1
COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database Amandine Dernoncourt,Jean Schmidt,Pierre Duhaut,Sophie Liabeuf,Valerie Gras-Champelet al. Fundamental & Clinical Pharmacology, 2022, 36 (1), pp.199-209. ⟨10.1111/fcp.12695⟩ Article dans une revue hal-03564792v1
Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase®) Amandine Dernoncourt,Sophie Liabeuf,Youssef Bennis,Kamel Masmoudi,Sandra Bodeauet al. BioDrugs, 2022, ⟨10.1007/s40259-022-00564-4⟩ Article dans une revue hal-03870209v1
Machine Learning-Based Urine Peptidome Analysis to Predict and Understand Mechanisms of Progression to Kidney Failure Ziad André Massy,Oriane Lambert,Marie Metzger,Mohammed Sedki,Adeline Chaubetet al. Kidney International Reports, 2022, 8 (3), pp.544-555. ⟨10.1016/j.ekir.2022.11.023⟩ Article dans une revue hal-04194829v1
Urgent-start dialysis in patients referred early to a nephrologist-the CKD-REIN prospective cohort study V. Fages,N. A. De Pinho,A. Hamroun,C. Lange,C. Combeet al. Nephrology Dialysis Transplantation, 2021, 36 (8), pp.1500-1510. ⟨10.1093/ndt/gfab170⟩ Article dans une revue inserm-03344370v1
Prescription of Direct Oral Anticoagulants to Patients with Moderate-to-Advanced CKD: Too Little or Just Right? S. Liabeuf,S.M. Laville,B. Bieber,C. Tu,B. Stengelet al. Kidney International Reports, 2021, 6 (9), pp.2496--2500. ⟨10.1016/j.ekir.2021.06.004⟩ Article dans une revue hal-03688195v1
Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease C. Villain,M. Metzger,S. Liabeuf,A. Hamroun,S. Lavilleet al. Journal of the American Medical Directors Association, 2021, S1525-8610 (21), pp.00939-7. ⟨10.1016/j.jamda.2021.10.019⟩ Article dans une revue inserm-03587209v1
Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results Lynda Cheddani,Sophie Liabeuf,Marie Essig,Renaud Snanoudj,Christian Jacquelinetet al. Nephrology Dialysis Transplantation, 2021, 36 (1), pp.176-184. ⟨10.1093/ndt/gfaa026⟩ Article dans une revue hal-03578405v1
POTENTIAL INTERACTIONS BETWEEN UREMIC TOXINS AND DRUGS: AN APPLICATION IN KIDNEY TRANSPLANT RECIPIENTS TREATED WITH CALCINEURIN INHIBITORS Camille Andre,Gabriel Choukroun,Youssef Bennis,Saïd Kamel,Sandra Bodeauet al. Nephrology Dialysis Transplantation, 2021, 36 (1) Article dans une revue hal-03565099v1
Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions? Lynda Cheddani,Ziad Massy,Sophie Liabeuf Clinical Kidney Journal, 2021, 14 (12), pp.2618-2619. ⟨10.1093/ckj/sfab154⟩ Article dans une revue hal-03578462v1
Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase (R)) Benjamin Batteux,Youssef Bennis,Sandra Bodeau,Kamel Masmoudi,Anne-Sophie Hurtel-Lemaireet al. BONE, 2021, 153, ⟨10.1016/j.bone.2021.116137⟩ Article dans une revue hal-03564790v1
Acute kidney injury associated with febuxostat and allopurinol: An analysis of disproportionality based on the global pharmacovigilance database, VigiBase (R) A. Rey,Benjamin Batteux,Kamel Masmoudi,Valérie Gras,Sophie Liabeuf Fundamental & Clinical Pharmacology, 2021, 35 (1, SI), pp.110-111 Article dans une revue hal-03578402v1
ADVERSE OUTCOMES ASSOCIATED WITH ORAL ANTITHROMBOTIC USE IN PATIENTS WITH MODERATE-TO-ADVANCED CHRONIC KIDNEY DISEASE Solene Laville,Oriane Lambert,Aghiles Hamroun,Marie Metzger,Christian Jacquelinetet al. Nephrology Dialysis Transplantation, 2021, 36 (1) Article dans une revue hal-03578403v1
Opinion and interpretation of new ``pregnancy'' pharmaceutical pictograms Valérie Gras,D. Bertrand,I. Piedeloup,Sophie Liabeuf Fundamental & Clinical Pharmacology, 2021, 35 (1, SI), pp.92 Article dans une revue hal-03578401v1
Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins Solene M. Laville,Ziad A. Massy,Saïd Kamel,Jean Marc Chillon,Gabriel Choukrounet al. Toxins, 2021, 13 (2), pp.91. ⟨10.3390/toxins13020091⟩ Article dans une revue hal-03572443v1
Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication M. Gras,Valérie Gras,J. Moragny,P. Delaunay,D. Laugieret al. Annales Pharmaceutiques Françaises, 2021, 79 (5), pp.522-529. ⟨10.1016/j.pharma.2021.02.003⟩ Article dans une revue hal-03578464v1
Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort study Z. A. Massy,E. Kolla,J. Ferrières,E. Bruckert,O. Lambertet al. Journal of Nephrology, 2021, 34 (5), pp.1467-1477. ⟨10.1007/s40620-021-01086-y⟩ Article dans une revue inserm-03344399v1
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? Sophie Liabeuf,Marion Pepin,Casper Franssen,Davide Viggiano,Sol Carriazoet al. Nephrology Dialysis Transplantation, 2021, ⟨10.1093/ndt/gfab223⟩ Article dans une revue hal-03451534v1
Consequences of oral antithrombotic use in patients with chronic kidney disease Solène M Laville,Oriane Lambert,Aghiles Hamroun,Marie Metzger,Christian Jacquelinetet al. Clinical and Translational Science., In press, ⟨10.1111/cts.13084⟩ Article dans une revue hal-03270687v1
PRESCRIPTION OF DIRECT ORAL ANTICOAGULANTS TO PATIENTS WITH MODERATE TO ADVANCED CKD : TOO LITTLE OR JUST RIGHT? Sophie Liabeuf,Solene M. Laville,Brian Bieber,Charlotte Tu,Benedicte Stengelet al. Nephrology Dialysis Transplantation, 2021, 36 (1), pp.307 Article dans une revue hal-03578404v1
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation Justine Marienne,Solène M. Laville,Pauline Caillard,Benjamin Batteux,Valérie Gras-Champelet al. Kidney International Reports, 2021, 6, pp.128 - 137. ⟨10.1016/j.ekir.2020.10.011⟩ Article dans une revue hal-03493124v1
Impact of the corticosteroid indication and administration route on overall survival and the tumor response after immune checkpoint inhibitor initiation Louis Gaucher,Leslie Adda,Alice Sejourne,Camille Joachim,Guillaume Chabyet al. Therapeutic Advances in Medical Oncology, 2021, 13, ⟨10.1177/1758835921996656⟩ Article dans une revue hal-03564796v1
Inappropriate self-medication practices: a reality among Amiens university students M. Gras,V. Champel,Kamel Masmoudi,Sophie Liabeuf Fundamental & Clinical Pharmacology, 2021, 35 (1, SI), pp.58 Article dans une revue hal-03578400v1
Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease Aurélie Lenglet,Mohamad Ali Rahali,François Ludovic Sauvage,Sophie Liabeuf,Gabriel Choukrounet al. Drugs in R&D, 2021, 21 (2), pp.231-238. ⟨10.1007/s40268-021-00350-7⟩ Article dans une revue hal-03287335v1
Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors Louis Gaucher,Leslie Adda,Alice Sejourne,Camille Joachim,Chaby Guillaumeet al. Therapeutic Advances in Medical Oncology, 2021, 13, ⟨10.1177/17588359211000591⟩ Article dans une revue hal-03564795v1
Atypical thrombosis associated with VaxZevria (R) (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres Valerie Gras-Champel,Sophie Liabeuf,Mariette Baud,Jean-Francois Albucher,Mehdi Benkebilet al. Thérapie, 2021, 76 (4), pp.369+. ⟨10.1016/j.therap.2021.05.007⟩ Article dans une revue hal-03578571v1
Drug prescription in patients with chronic kidney disease: a true challenge Sophie Liabeuf,M. Laville Nephrology Dialysis Transplantation, 2021, 36 (3), pp.385-386. ⟨10.1093/ndt/gfaa164⟩ Article dans une revue inserm-03328424v1
Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19 Benjamin Batteux,Sandra Bodeau,Valerie Gras-Champel,Sophie Liabeuf,Jean-Philippe Lanoixet al. British Journal of Clinical Pharmacology, 2021, 87 (3), pp.1547-1553. ⟨10.1111/bcp.14489⟩ Article dans une revue hal-03564802v1
Hypoexcitability of Motoneurons: An Early Pathological Sign in ALS J. Durand,Anton Filipchuk,A. Pambo-Pambo,F. Gaudel,Sophie Liabeufet al. Neuroscience, 2021, 465, pp.233-234. ⟨10.1016/j.neuroscience.2021.03.015⟩ Article dans une revue hal-03295895v1
Réalité de la prise en charge de la maladie rénale chronique en néphrologie en France : étude de cohorte CKD-REIN Natalia Alencar de Pinho,Jean-Baptiste Capgras,Élodie Speyer,Christian Combe,Denis Fouqueet al. Néphrologie & Thérapeutique, 2021, ⟨10.1016/j.nephro.2021.06.008⟩ Article dans une revue hal-03398645v1
EARLY STEROID WITHDRAWAL HAS A POSITIVE EFFECT ON BONE KIDNEY TRANSPLANT RECIPIENTS: A PROPENSITY SCORE STUDY WITH INVERSE PROBABILITY-OF-TREATMENT WEIGHTING Benjamin Batteux,Valerie Gras-Champel,Mathilde Lando,Francois Brazier,Isabelle Desailly-Henryet al. Nephrology Dialysis Transplantation, 2020, 35 (3), pp.1201 Article dans une revue hal-03573038v1
Adverse Drug Reactions in Patients with CKD Solène Laville,Valérie Gras-Champel,Julien Moragny,Marie Metzger,Christian Jacquelinetet al. Clinical Journal of the American Society of Nephrology, 2020, 15 (8), pp.1090-1102. ⟨10.2215/cjn.01030120⟩ Article dans une revue hal-02958497v1
The drugs that mostly frequently induce gynecomastia: A national case - noncase study Benjamin Batteux,Benoit Llopis,Charlotte Muller,Charles Khouri,Julien Moragnyet al. Thérapie, 2020, 75 (3), pp.225-238. ⟨10.1016/j.therap.2019.06.001⟩ Article dans une revue hal-03578660v1
Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation Benjamin Batteux,Sandra Bodeau,Camille Andre,Anne-Sophie Hurtel-Lemaire,Valerie Gras-Champelet al. Toxins, 2020, 12 (11), ⟨10.3390/toxins12110715⟩ Article dans une revue hal-03564798v1
Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease Sophie Liabeuf,Solene M. Laville,Griet Glorieux,Lynda Cheddani,Francois Brazieret al. International Journal of Molecular Sciences, 2020, 21 (6), ⟨10.3390/ijms21062031⟩ Article dans une revue hal-03573041v1
Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function Lynda Cheddani,Jean Philippe Haymann,Sophie Liabeuf,Nahid Tabibzadeh,Jean-Jacques Boffaet al. Clinical Kidney Journal, 2020, 14 (4), pp.1244 - 1254. ⟨10.1093/ckj/sfaa120⟩ Article dans une revue hal-03230919v1
Statin-associated myasthenia: A case report and literature review Valerie Gras-Champel,Ines Masmoudi,Benjamin Batteux,Philippe-Edouard Merle,Sophie Liabeufet al. Thérapie, 2020, 75 (3), pp.301-309. ⟨10.1016/j.therap.2019.07.004⟩ Article dans une revue hal-03578661v1
Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study Sophie Liabeuf,O. Lambert,M. Metzger,A. Hamroun,M. Lavilleet al. British Journal of Clinical Pharmacology, 2020, 87 (7), pp.2967-2976. ⟨10.1111/bcp.14713⟩ Article dans une revue inserm-03269073v1
Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury Camille André,Youssef Bennis,Dimitri Titeca-Beauport,Pauline Caillard,Yan Cluetet al. Journal of Chromatography B - Analytical Technologies in the Biomedical and Life Sciences, 2020, 1152, pp.122234 -. ⟨10.1016/j.jchromb.2020.122234⟩ Article dans une revue hal-03490861v1
Impact of age on cardiovascular drug use in patients with chronic kidney disease Cédric Villain,Sophie Liabeuf,Marie Metzger,Christian Combe,Denis Fouqueet al. Clinical Kidney Journal, 2020, 13 (2), pp.199-207. ⟨10.1093/ckj/sfz063⟩ Article dans une revue hal-02572053v1
Association between renin-angiotensin system inhibitors and COVID-19 complications Sophie Liabeuf,Julien Moragny,Youssef Bennis,Benjamin Batteux,Etienne Brochotet al. European Heart Journal - Cardiovascular Pharmacotherapy, 2020, 7 (5), pp.426-434. ⟨10.1093/ehjcvp/pvaa062⟩ Article dans une revue hal-03564801v1
Uremic Toxins and Vascular Dysfunction I. Six,Nadia Flissi,Gaëlle Lenglet,Loïc Louvet,Saïd Kamelet al. Toxins, 2020, 12 (6), pp.404. ⟨10.3390/toxins12060404⟩ Article dans une revue hal-03346161v1
Long- Versus Short-Acting Erythropoiesis-Stimulating Agent Type and Mortality Angelo Karaboyas,Friedrich K. Port,Ziad A. Massy,Francesco Locatelli,Aleix Caseset al. Kidney International Reports, 2020, 6 (1), pp.214-218. ⟨10.1016/j.ekir.2020.10.003⟩ Article dans une revue hal-03578662v1
Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting Benjamin Batteux,Valerie Gras-Champel,Mathilde Lando,Francois Brazier,Romuald Mentaverriet al. Therapeutic advances in musculoskeletal disease, 2020, 12, ⟨10.1177/1759720X20953357⟩ Article dans une revue hal-03564799v1
Évaluation et impact des pictogrammes « grossesse » apposés sur les conditionnements extérieurs des médicaments : enquête auprès de 281 femmes Débora Bertrand,Isabelle Piedeloup,Salah Mattoug,Sophie Liabeuf,Valérie Gras-Champel Thérapie, 2020, 75, pp.449 - 458. ⟨10.1016/j.therap.2019.11.001⟩ Article dans une revue hal-03492616v1
Self-medication practices and their characteristics among French university students Marion Gras,Valérie Champel,Kamel Masmoudi,Sophie Liabeuf Thérapie, 2020, 75, pp.419 - 428. ⟨10.1016/j.therap.2020.02.019⟩ Article dans une revue hal-03493748v1
Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database Valerie Gras-Champel,Benjamin Batteux,Kamel Masmoudi,Sophie Liabeuf Muscle & Nerve, 2019, 60 (4), pp.382-386. ⟨10.1002/mus.26637⟩ Article dans une revue hal-03578807v1
International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps Sophie Liabeuf,Keith Mccullough,Eric W. Young,Ronald Pisoni,Jarcy Zeeet al. BONE, 2019, 129, pp.115058 -. ⟨10.1016/j.bone.2019.115058⟩ Article dans une revue hal-03487829v1
Risk of acute kidney injury, end-stage kidney disease and mortality associated with proton pump inhbitor use in patients with chronic kidney disease Sophie Liabeuf,Oriane Lambert,Marie Metzger,Christian Combe,Aghiles Hamrounet al. Nephrology Dialysis Transplantation, 2019, 34 (1), pp.SP211. ⟨10.1093/ndt/gfz103.SP211⟩ Article dans une revue hal-03578811v1
Reply to ``Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!'' by Stamp et al. Solene M. Laville,Benedicte Stengel,Ziad A. Massy,Sophie Liabeuf British Journal of Clinical Pharmacology, 2019, 85 (6, SI), pp.1380-1381. ⟨10.1111/bcp.13924⟩ Article dans une revue hal-03578809v1
ACHIEVEMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL EUROPEAN SOCIETY OF CARDIOLOGY TARGETS IN CHRONIC KIDNEY DISEASE: A PROSPECTIVE COHORT STUDY Ziad Massy,Jean Ferrieres,Eric Bruckert,Celine Lange,Sophie Liabeufet al. Nephrology Dialysis Transplantation, 2019, 34 (supplement 1), pp.FP384. ⟨10.1093/ndt/gfz106.FP384⟩ Article dans une revue hal-03578812v1
Risk profile, quality of life and care of patients with moderate and advanced CKD : The French CKD-REIN Cohort Study Benedicte Stengel,Marie Metzger,Christian Combe,Denis Jacquelinet,Serge Briançonet al. Nephrology Dialysis Transplantation, 2019, 34 (2), pp.277-286. ⟨10.1093/ndt/gfy058⟩ Article dans une revue hal-01807654v1
Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy Carole Aubert,Sophie Liabeuf,Chloé Amouyal,Salim Kemel,Frédérique Lajat-Kisset al. Diabetology and Metabolic Syndrome, 2019, 11 (2), pp.32. ⟨10.1186/s13098-019-0429-7⟩ Article dans une revue hal-02125115v1
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients Ophélie Fourdinier,Eva Schepers,Valérie Metzinger-Le Meuth,Griet Glorieux,Sophie Liabeufet al. Scientific Reports, 2019, 9 (1), ⟨10.1038/s41598-019-41101-8⟩ Article dans une revue hal-02625556v1
Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study Amayelle Rey,Benjamin Batteux,Solene M. Laville,Justine Marienne,Kamel Masmoudiet al. Arthritis Research & Therapy, 2019, 21 (1), ⟨10.1186/s13075-019-2011-y⟩ Article dans une revue hal-03578806v1
Incidence and determinants of adverse drug reactions in patients with CKD from the CKD-rein cohort study Solene Laville,Marie Metzger,Benedicte Stengel,Christian Jacquelinet,Maurice Lavilleet al. Nephrology Dialysis Transplantation, 2019, 34 (Suppl 1), pp.FP376. ⟨10.1093/ndt/gfz106.FP376⟩ Article dans une revue hal-03578808v1
Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD Ziad Massy,Jean Ferrières,Eric Bruckert,Céline Lange,Sophie Liabeufet al. Kidney International Reports, 2019, 4 (11), pp.1546-1554. ⟨10.1016/j.ekir.2019.07.014⟩ Article dans une revue hal-02378942v1
The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial Youssef Bennis,Yan Cluet,Dimitri Titeca-Beauport,N. El Esper,P. Urenaet al. Toxins, 2019, 11 (5), ⟨10.3390/toxins11050279⟩ Article dans une revue hal-02195307v1
Ischaemic colitis associated with intravitreal administration of aflibercept: A first case report Benjamin Batteux,Valerie Gras,Yanis Mahboud,Sophie Liabeuf,Youssef Benniset al. British Journal of Clinical Pharmacology, 2019, 85 (4), pp.845-848. ⟨10.1111/bcp.13853⟩ Article dans une revue hal-03564806v1
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients? Aurelie Lenglet,Nicolas Fabresse,Meline Taupin,Cathy Gomila,Sophie Liabeufet al. Drugs, 2019, 79 (8), pp.855-862. ⟨10.1007/s40265-019-01118-9⟩ Article dans une revue hal-03578810v1
Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury Laurens Veldeman,Jill Vanmassenhove,Wim van Biesen,Ziad A. Massy,Sophie Liabeufet al. International Urology and Nephrology, 2019, 51 (2), pp.293-302. ⟨10.1007/s11255-018-2056-x⟩ Article dans une revue hal-03578813v1
Guideline attainment and morbidity/mortality rates in a large cohort of European haemodialysis patients (EURODOPPS) Sophie Liabeuf,Ayesha Sajjad,Anneke Kramer,Brian Bieber,Keith Mcculloughet al. Nephrology Dialysis Transplantation, 2019, 34 (12), pp.2105-2110. ⟨10.1093/ndt/gfz049⟩ Article dans une revue hal-03578805v1
From old uraemic toxins to new uraemic toxins: place of `omics Ziad A. Massy,Sophie Liabeuf Nephrology Dialysis Transplantation, 2018, 33 (3), pp.2-5. ⟨10.1093/ndt/gfy212⟩ Article dans une revue hal-03578865v1
INTERNATIONAL VARIATION IN MBD MEASUREMENT, VITAMIN D PRESCRIPTION, AND PHOSPHATE BINDER PRESCRIPTION PATTERNS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE Sophie Liabeuf,Keith Mccullough,Ronald Pisoni,Jarcy Zee,Helmut Reichelet al. Nephrology Dialysis Transplantation, 2018, 33 (1) Article dans une revue hal-03578869v1
Higher parathyroid hormone levels are associated with increased below-the-knee arterial calcification in type 2 diabetes Z. Massy,Romuald Mentaverri,O. Bourron,Saïd Kamel,Aurélien Maryet al. Diabetes & Metabolism, 2018, 44 (3), pp.305-308. ⟨10.1016/j.diabet.2017.04.008⟩ Article dans une revue hal-03564973v1
Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation Sophie Liabeuf,Lynda Cheddani,Ziad A. Massy Toxins, 2018, 10 (6), ⟨10.3390/toxins10060229⟩ Article dans une revue hal-03578867v1
Expression sérique et intérêt pronostique de miR-126 et miR-223 dans la maladie rénale chronique O. Fourdinier,E. Schepers,V. Metzinger-Le Meuth,G. Glorieux,S. Liabeufet al. Néphrologie & Thérapeutique, 2018, 14 (5), pp.380. ⟨10.1016/j.nephro.2018.07.293⟩ Article dans une revue hal-04164800v1
Cognitive Impairments and Dysexecutive Behavioral Disorders in Chronic Kidney Disease Laurent Puy,Jean-Marc Bugnicourt,Sophie Liabeuf,Lucie Desjardins,Martine Rousselet al. Journal of Neuropsychiatry and Clinical Neurosciences, 2018, 30 (4), pp.310-317. ⟨10.1176/appi.neuropsych.18030047⟩ Article dans une revue hal-03572445v1
Prevalence of inappropriate drug prescription in patients with chronic kidney disease and the impact of equation used to estimate kidney function S. Laville,M. Metzger,B. Stengel,C. Jacquelinet,C. Combeet al. Fundamental & Clinical Pharmacology, 2018, 32 (1, SI), pp.39 Article dans une revue hal-03578866v1
EVALUATION OF THE ADEQUACY OF DRUG PRESCRIPTIONS IN PATIENTS WITH MODERATE OR ADVANCED CHRONIC KIDNEY DISEASE : RESULTS FROM THE FRENCH CKD-REIN COHORT Solene Laville,Marie Metzger,Benedicte Stengel,Christian Jacquelinet,Christian Combeet al. Nephrology Dialysis Transplantation, 2018, 33 (1), ⟨10.1093/ndt/gfy104.FP338⟩ Article dans une revue hal-03578868v1
Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort Solène M Laville,Marie Metzger,Bénédicte Stengel,Christian Jacquelinet,Christian Combeet al. British Journal of Clinical Pharmacology, 2018, 84 (12), pp.2811--2823. ⟨10.1111/bcp.13738⟩ Article dans une revue hal-02003310v1
Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients Aurelien Mary,Agnes Hartemann,Sophie Liabeuf,Carole Elodie Aubert,Salim Kemelet al. Cardiovascular Diabetology, 2017, 16, ⟨10.1186/s12933-017-0509-7⟩ Article dans une revue hal-03555488v1
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study (vol 32, pg 870, 2017) Aurelie Lenglet,Sophie Liabeuf,Najeh El Esper,Sandrine Brisset,Janette Mansouret al. Nephrology Dialysis Transplantation, 2017, 32 (9), pp.1597. ⟨10.1093/ndt/gfx249⟩ Article dans une revue hal-03564975v1
The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysis Simon D. S. Fraser,Anthony Fenton,Scott Harris,Adam Shardlow,Sophie Liabeufet al. Mayo Clinic Proceedings, 2017, 92 (11), pp.1671-1681. ⟨10.1016/j.mayocp.2017.08.021⟩ Article dans une revue hal-03578870v1
Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study Benjamin Brigant,Valérie Metzinger-Le Meuth,Ziad Massy,Nathalie Mckay,Sophie Liabeufet al. Clinical Kidney Journal, 2017, 10 (1), pp.30-37. ⟨10.1093/ckj/sfw060⟩ Article dans une revue hal-01790133v1
The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database Marion Pierson-Marchandise,Valerie Gras,Julien Moragny,Joelle Micallef,Louise Gaboriauet al. British Journal of Clinical Pharmacology, 2017, 83 (6), pp.1341-1349. ⟨10.1111/bcp.13216⟩ Article dans une revue hal-03574256v1
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD Sophie Liabeuf,Jean-Philippe Ryckelynck,Najeh El Esper,Pablo Urena,Christian Combeet al. Clinical Journal of the American Society of Nephrology, 2017, 12 (12), pp.1930-1940. ⟨10.2215/CJN.03030317⟩ Article dans une revue hal-03574250v1
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study Aurelie Lenglet,Sophie Liabeuf,Najeh El Esper,Sandrine Brisset,Janette Mansouret al. Nephrology Dialysis Transplantation, 2017, 32 (5), pp.870-879. ⟨10.1093/ndt/gfw042⟩ Article dans une revue hal-03564976v1
Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country's healthcare expenditure and nephrologist workforce? Sophie Liabeuf,Karlijn J. van Stralen,Fergus Caskey,Francesca Tentori,Ronald L. Pisoniet al. Nephrology Dialysis Transplantation, 2017, 32 (10), pp.1737-1749. ⟨10.1093/ndt/gfw409⟩ Article dans une revue hal-03578871v1
The drugs that most frequently induce acute kidney injury: a case-noncase study of pharmacovigilance database M. Pierson-Marchandise,Valérie Gras,J. Moragny,J. Micallef,L. Gaboriauet al. Fundamental & Clinical Pharmacology, 2017, 31 (1, SI), pp.35 Article dans une revue hal-03574260v1
THE IMPACT OF SEVELAMER ON GUT DERIVED UREMIC TOXINS LEVELS : RESULTS FROM A MULTICENTER, DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED CLINICAL TRIAL Sophie Liabeuf,Youssef Bennis,Jennifer Romezin,Jean-Philippe Ryckelynck,Najeh El Esperet al. Nephrology Dialysis Transplantation, 2017, 32 (3), pp.199 Article dans une revue hal-03564814v1
Association of advanced age with concentrations of uraemic toxins in CKD Merita Rroji,Sunny Eloot,Annemie Dhondt,Wim van Biesen,Griet Glorieuxet al. Journal of Nephrology, 2016, 29 (1), pp.81-91. ⟨10.1007/s40620-015-0195-z⟩ Article dans une revue hal-03948722v1
N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin Aurelie Lenglet,Sophie Liabeuf,Sandra Bodeau,Loïc Louvet,Aurelien Maryet al. Toxins, 2016, 8 (11), ⟨10.3390/toxins8110339⟩ Article dans une revue hal-03568256v1
In geriatric patients, delirium symptoms are related to the anticholinergic burden Moustafa Naja,Jadwiga Zmudka,Sanaa Hannat,Sophie Liabeuf,Jean-Marie Serotet al. Geriatrics & Gerontology International, 2016, 16 (4), pp.424-431. ⟨10.1111/ggi.12485⟩ Article dans une revue istex hal-03948894v1
Vascular calcifications, the hidden side effects of vitamin K antagonists Youssef Bennis,Subashini Vengadessane,Sandra Bodeau,Valerie Gras,Giampiero Briccaet al. Thérapie, 2016, 71 (4), pp.355-363. ⟨10.1016/j.therap.2015.12.004⟩ Article dans une revue hal-03564817v1
Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists Sophie Liabeuf,Kamel Masmoudi,Lucie-Marie Scailteux,Julien Moragny,Henri Massonet al. Medicine, 2016, 95 (39), ⟨10.1097/MD.0000000000004762⟩ Article dans une revue hal-03563588v1
Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess? Sophie Liabeuf,Cedric Villain,Ziad A. Massy Clinical Science, 2016, 130 (23), pp.2209-2216. ⟨10.1042/CS20160393⟩ Article dans une revue hal-03578874v1
IMPLEMENTATION OF GUIDELINES ON MINERAL BONE DISEASE IN EUROPE, RESULTS FROM EURODOPPS Sophie Liabeuf,Karlijn J. van Stralen,Francesca Tentori,Christian Combre,Kitty J. Jageret al. Nephrology Dialysis Transplantation, 2016, 31 (1), pp.1529 Article dans une revue hal-03578875v1
Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes Sophie Liabeuf,Lucie Desjardins,Ziad A. Massy,Francois Brazier,Pierre Francois Westeelet al. Circulation Journal, 2016, 80 (3), pp.722-730. ⟨10.1253/circj.CJ-15-0949⟩ Article dans une revue hal-03574435v1
European disparity in drugs prescription in hemodialysis patients - Results from EURODOPPS Sophie Liabeuf,K. van Stralen,K. Jager,C. Combe,F. Tentoriet al. Fundamental & Clinical Pharmacology, 2016, 30 (1, SI), pp.7 Article dans une revue hal-03578876v1
[Pathophysiological mechanisms of vascular calcification]. Lucie Hénaut,Romuald Mentaverri,Sophie Liabeuf,Anne-Sophie Bargnoux,Pierre Delanayeet al. Annales de Biologie Clinique, 2015, pp.271-87. ⟨10.1684/abc.2015.1044⟩ Article dans une revue hal-01773113v1
[Biomarkers of vascular calcifications: what are analytical limits to apply &quot;research-grade&quot; diagnostic kits into daily practice?]. Anne-Sophie Bargnoux,Josiane Arnaud,Etienne Cavalier,Laurence Piéroni,Saïd Kamelet al. Annales de Biologie Clinique, 2015, pp.323-32. ⟨10.1684/abc.2015.1043⟩ Article dans une revue hal-01756867v1
Ulceration of the oral mucosa following direct contact with ferrous sulfate in elderly patients: a case report and a review of the French National Pharmacovigilance Database. Sophie Liabeuf,Valérie Gras,Julien Moragny,Marie-Laure Laroche,Michel Andrejaket al. Clin Interv Aging, 2014, 9, pp.737-40. ⟨10.2147/CIA.S58394⟩ Article dans une revue hal-00999728v1
Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein. Sophie Liabeuf,Bourron Olivier,Cees Vemeer,Elke Theuwissen,Elke Magdeleynset al. Cardiovascular Diabetology, 2014, 13 (1), pp.85. ⟨10.1186/1475-2840-13-85⟩ Article dans une revue inserm-00989533v1
Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification Julien Paccou,Cédric Boudot,Cédric Renard,Sophie Liabeuf,Said Kamelet al. Arthritis Research & Therapy, 2014, 16 (4), pp.412. ⟨10.1186/s13075-014-0412-5⟩ Article dans une revue hal-04444981v1
Coronary and Abdominal Aorta Calcification in Rheumatoid Arthritis: Relationships with Traditional Cardiovascular Risk Factors, Disease Characteristics, and Concomitant Treatments Julien Paccou,Cédric Renard,Sophie Liabeuf,Said Kamel,Patrice Fardelloneet al. Journal of Rheumatology, 2014, 41 (11), pp.2137-2144. ⟨10.3899/jrheum.140239⟩ Article dans une revue hal-04444990v1
The Relationships Between Serum Sclerostin, Bone Mineral Density, and Vascular Calcification in Rheumatoid Arthritis Julien Paccou,R. Mentaverri,C. Renard,S. Liabeuf,P. Fardelloneet al. Journal of Clinical Endocrinology and Metabolism, 2014, 99 (12), pp.4740-4748. ⟨10.1210/jc.2014-2327⟩ Article dans une revue hal-04444980v1
Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2 Rémi Bos,K. Sadlaoud,P. Boulenguez,D. Buttigieg,Sophie Liabeufet al. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110 (1), pp.348-353. ⟨10.1073/pnas.1213680110⟩ Article dans une revue hal-02009356v1
Is the effect of mobile phone radiofrequency waves on human skin perfusion non-thermal ? Nathalie Loos,György Thuróczy,Rania Ghosn,Valérie Brenet-Dufour,Sophie Liabeufet al. Microcirculation, 2013, 20 (7), pp.629-636. ⟨10.1111/micc.12062⟩ Article dans une revue ineris-00961812v1
Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease Lucie Desjardins,Sophie Liabeuf,Aurélie Lenglet,Horst-Dieter Lemke,Raymond Vanholderet al. Toxins, 2013, 5 (11), pp.2058-2073. ⟨10.3390/toxins5112058⟩ Article dans une revue hal-04139791v1
Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients Aurélie Lenglet,Sophie Liabeuf,Pauline Guffroy,Albert Fournier,Michel Brazieret al. Drugs in R&D, 2013, 13 (3), pp.165-173. ⟨10.1007/s40268-013-0024-6⟩ Article dans une revue hal-04139792v1
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients Rodrigo Bueno De Oliveira,Sophie Liabeuf,Hirokazu Okazaki,Aurélie Lenglet,Lucie Desjardinset al. Clinical Kidney Journal, 2013, 6 (1), pp.63-70. ⟨10.1093/ckj/sfs176⟩ Article dans une revue hal-04139795v1
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients Rodrigo B. De Oliveira,Sophie Liabeuf,Hirokazu Okazaki,Aurélie Lenglet,Lucie Desjardinset al. Nephrology Dialysis Transplantation, 2013, 28 (1), pp.165 Article dans une revue hal-04139794v1
Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins? Sophie Liabeuf,Griet Glorieux,Aurélie Lenglet,Momar Diouf,Eva Scheperset al. PLoS ONE, 2013, 8 (6), ⟨10.1371/journal.pone.0067168⟩ Article dans une revue hal-04139793v1
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages L. Desjardins,S. Liabeuf,C. Renard,Aurélie Lenglet,H-D. Lemkeet al. Osteoporosis International, 2012, 23 (7), pp.2017-2025. ⟨10.1007/s00198-011-1838-0⟩ Article dans une revue istex hal-04139799v1
Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease Nathalie Neirynck,Sunny Eloot,Griet Glorieux,Daniela V. Barreto,Fellype C. Barretoet al. PLoS ONE, 2012, 7 (8), ⟨10.1371/journal.pone.0044201⟩ Article dans une revue hal-04139798v1
Effects of GSM 900 MHz on middle cerebral artery blood flow assessed by transcranial doppler sonography Rania Ghosn,György Thuróczy,Nathalie Loos,Valérie Brenet-Dufour,Sophie Liabeufet al. Radiation Research, 2012, 178 (6), pp.543-550. ⟨10.1667/RR3007.1⟩ Article dans une revue ineris-00963406v1
Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease Aurélie Lenglet,Sophie Liabeuf,Lucie Desjardins,Nathalie Neirynck,Griet Glorieuxet al. The International Journal of Artificial Organs, 2012, 35 (11), pp.959-968. ⟨10.5301/ijao.5000124⟩ Article dans une revue hal-04139797v1
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients Sophie Liabeuf,Aurélie Lenglet,Lucie Desjardins,Nathalie Neirynck,Griet Glorieuxet al. Kidney International, 2012, 82 (12), pp.1297-1303. ⟨10.1038/ki.2012.301⟩ Article dans une revue hal-04139796v1
Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease Aurélie Terrier-Lenglet,Aude Nollet,Sophie Liabeuf,Daniela V. Barreto,Michel Brazieret al. Néphrologie & Thérapeutique, 2011, 7 (4), pp.219-224. ⟨10.1016/j.nephro.2010.12.009⟩ Article dans une revue istex hal-04139714v1
Prognostic Implication of Plasma Osteopontin Levels in Patients with Chronic Kidney Disease Daniela V. Barreto,Aurélie Lenglet,Sophie Liabeuf,Axel Kretschmer,Fellype C. Barretoet al. Nephron Clinical Practice, 2011, 117 (4), pp.C363-C372. ⟨10.1159/000321520⟩ Article dans une revue hal-04139800v1

Poster de conférence (7)

Anticholinergic drugs and anticholinergic adverse drug reactions: Insights from pharmacovigilance reports P. E. Pecquet,V. Gras,P. Schiro,S. Pinel,Solène Lavilleet al. Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2025, Grenoble, France. Wiley, Fundamental & Clinical Pharmacology, 39 (S1), pp.PS-068, 2025, Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 24 June 2025, Grenoble, France Poster de conférence hal-05471346v1
Polypharmacy and chronic kidney disease: A dangerous combination ? A. Mouheb,Solène Laville,V. Gras,J. Moragny,N. Alencar de Pinhoet al. Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2025, Grenoble, France. Wiley, Fundamental & Clinical Pharmacology, 39 (S1), pp.PS-037, 2025, Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 24 June 2025, Grenoble, France Poster de conférence hal-05471237v1
Association between Plasma Alpha 1-Antitrypsin Levels and Kidney Failure in Patients with CKD Antoine Créon,Julie Klein,Sophie Liabeuf,Céline Lange,Christian Jacquelinetet al. Kidney Week, Oct 2024, San Diego (CA), United States. Journal of American Society of Nephrology, 35 (10S), pp.SA-PO1105, 2024, ⟨10.1681/ASN.2024fhch029h⟩ Poster de conférence hal-05070640v1
Beta-Blocker Prescriptions in Nondialysis-Dependent Patients with CKD: The French CKD-REIN Study Margaux Costes-Albrespic,Sophie Liabeuf,Solene Laville,Oriane Lambert,Ziad Massyet al. Kidney Week, Oct 2024, San Diego (CA), United States. Journal of American Society of Nephrology, 35 (10S), pp.FR-PO1124, 2024, ⟨10.1681/ASN.2024avm1v4gv⟩ Poster de conférence hal-05069443v1
AKI as a Key Predictor of Cardiovascular Events in Patients with CKD: The CKD-REIN Study Aghiles Hamroun,Estelle Aymes,Luc Frimat,Maurice Laville,Céline Langeet al. Kidney Week, Oct 2024, San Diego (CA), United States. Journal of American Society of Nephrology, 35 (10S), pp.FR-PO370, 2024, ⟨10.1681/ASN.2024bzje0ae9⟩ Poster de conférence hal-05070904v1
PS-011. Skin necrosis after subcutaneously administered ceftriaxone: Cases notified to the French national pharmacovigilance database P. E. Pecquet,S. Laville,N. Massy,D. Dauge,J. Moragnyet al. Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2023, Limoges (France), France. Fundamental and Clinical Pharmacology, 37 (S1), pp.92-209, 2023, ⟨10.1111/fcp.12908⟩ Poster de conférence hal-04265955v1
Toxic microbiome and chronic kidney disease: insights from the CKD-REIN cohort study Manolo Laiola,Sandra Wagner,Laetitia Koppe,Islam Amine Larabi,Florence Thirionet al. the 9th International Human Microbiome Consortium (IHMC) Congress, Nov 2022, Kobe, Japan Poster de conférence hal-04713459v1

Communication dans un congrès (10)

#2591 The anticholinergic burden in patients with chronic kidney disease: patterns, risk factors, and the link with cognitive impairment Agathe Mouheb,Hélène Levassort,Ziad Massy,Natalia Alencar de Pinho,Marion Pepinet al. 62nd ERA Congress, 4-7 June 2025, European Renal Association, Jun 2025, Vienna (Austria), Austria. pp.Meeting Abstract 2591, ⟨10.1093/ndt/gfaf116.1450⟩ Communication dans un congrès hal-05448980v1
#1676 Association between furosemide and serum uremic toxins levels in patients with chronic kidney disease Margaux Costes-Albrespic,Natalia Alencar de Pinho,Islam Amine Larabi,Solene Laville,Christian Jacquelinetet al. 62nd ERA Congress, 4-7 June 2025, European Renal Association, Jun 2025, Vienna (Austria), Austria. pp.Meeting Abstract 1676, ⟨10.1093/ndt/gfaf116.0524⟩ Communication dans un congrès hal-05448627v1
ACHIEVEMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL EUROPEAN SOCIETY OF CARDIOLOGY TARGETS IN CHRONIC KIDNEY DISEASE: A PROSPECTIVE COHORT STUDY Ziad Massy,Jean Ferrieres,Eric Bruckert,Celine Lange,Sophie Liabeufet al. 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Jun 2019, Budapest, Hungary Communication dans un congrès hal-03969900v1
Effets thermiques locaux potentialisés par les effets des ondes radiofréquences émises par téléphonie mobile sur la vasomotricité cutanée Nathalie Loos,René de Seze,Jean-Pierre Libert,György Thuróczy,Valérie Brenet-Dufouret al. 9. Congrès national de radioprotection (SFRP 2013), Jun 2013, Bordeaux, France Communication dans un congrès ineris-00971180v1
Acute exposure to mobile phone and assessment of internal cerebral circulation in young healthy subjects : a transcranial Doppler study Rania Ghosn,György Thuróczy,Nathalie Loos,Valérie Brenet-Dufour,Sophie Liabeufet al. 7. International Workshop on Biological Effects of Electromagnetic Fields (IWSBEEMF), Oct 2012, Malte, Malta. pp.NC Communication dans un congrès ineris-00973681v1
Modulation of the skin vasoconstrictor tone by 900 Mhz GSM radiofrequency field Nathalie Loos,René de Seze,Valérie Brenet-Dufour,Rania Ghosn,Sophie Liabeufet al. 34. Annual Conference of the Bioelectromagnetics Society (BEMS), Jun 2012, Brisbane, Australia Communication dans un congrès ineris-00970962v1
Acute exposure to mobile phone and assessment of internal cerebral circulation : a transcranial doppler study Rania Ghosn,György Thuróczy,Nathalie Loos,Valérie Brenet-Dufour,Sophie Liabeufet al. 34. Annual Conference of the Bioelectromagnetics Society (BEMS), Jun 2012, Brisbane, Australia Communication dans un congrès ineris-00970998v1
Effets spécifiques de l'exposition radiofréquence de téléphone mobile sur le tonus vasomoteur cutané Nathalie Loos,Valérie Brenet-Dufour,Rania Ghosn,Sophie Liabeuf,René de Seze Colloque national du réseau ANTIOPES "Ecotoxicologie et Toxicologie environnementale : nouveaux concepts, nouveaux outils", Mar 2012, Avignon, France Communication dans un congrès ineris-00976314v1
Acute effects of radiofrequency exposure to mobile phone upon human cutaneous microvascular tone Nathalie Loos,Valérie Brenet-Dufour,Rania Ghosn,Sophie Liabeuf,Brahim Selmaouiet al. EUROEM 2012, Jul 2012, Toulouse, France Communication dans un congrès ineris-00971026v1
Effets spécifiques d'une exposition aux ondes radiofréquences de téléphone mobile sur le contrôle nerveux autonome du tonus vasomoteur cutané Nathalie Loos,René de Seze,Valérie Brenet-Dufour,Rania Ghosn,Sophie Liabeufet al. Journées Scientifiques URSI-France JS'12 "Champs électromagnétiques : de la dosimétrie à la santé humaine", Apr 2012, Paris, France. pp.143-145 Communication dans un congrès ineris-00973655v1

Chapitre d'ouvrage (1)

Middle-Molecule Uremic Toxins and Outcomes in Chronic Kidney Disease Ziad A. Massy,Sophie Liabeuf Ronco, C. EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 191, pp.8-17, 2017, Contributions to Nephrology, 978-3-318-06117-8; 978-3-318-06116-1. ⟨10.1159/000479252⟩ Chapitre d'ouvrage istex hal-03578873v1